Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodies.

bioRxiv : the preprint server for biology·2026

Same author

Towards modeling phage therapy.

PLoS computational biology·2026

Same author

INHERITANCE OF INTRACELLULAR VIRAL RNA IN A MULTISCALE MODEL OF HEPATITIS C INFECTION.

SIAM journal on applied mathematics·2026

Same author

AZD5582 robustly reactivates latently infected cells and clears the majority of those reactivated from the SIV reservoir.

bioRxiv : the preprint server for biology·2026

Same author

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action.

Clinical pharmacology and therapeutics·2026

Same author

Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution.

Microbiology spectrum·2026

Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026

Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026

Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026

Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026

Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026

Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 17, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

Variant-Specific Viral Kinetics in Acute COVID-19.

Ruy M Ribeiro¹, Manish C Choudhary², Rinki Deo²

¹Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, New Mexico.

The Journal of Infectious Diseases

|August 31, 2023

Summary

This summary is machine-generated.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral kinetics varied by variant, with Delta showing the highest viral load. However, all variants were cleared efficiently by the host after reaching peak viral load.

Keywords:

COVID-19 variant viral kinetics

More Related Videos

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

Related Experiment Videos

Last Updated: Jul 17, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

Area of Science:

Virology
Infectious Diseases
Epidemiology

Background:

Understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral kinetics is crucial for explaining transmission and pathogenesis.
Previous studies have not fully elucidated variant-specific differences in viral load dynamics.

Purpose of the Study:

To evaluate SARS-CoV-2 viral kinetics across different variants (Alpha, Delta, Epsilon, Gamma) in nasal swabs.
To compare viral load, time to peak, and viral clearance among these variants.

Main Methods:

Analysis of nasal swab samples from placebo recipients in the ACTIV-2/A5401 trial.
Quantification of SARS-CoV-2 RNA to determine viral kinetics.
Comparison of viral load parameters across Alpha, Delta, Epsilon, and Gamma variants.

Main Results:

The Delta variant exhibited the highest maximum viral load and the shortest time from symptom onset to peak viral load.
No significant differences were observed in the time to viral clearance among the variants.
Viral decline followed a biphasic pattern, with distinct differences in the second phase decay rates among variants.

Conclusions:

Variant-specific differences in SARS-CoV-2 viral kinetics exist, particularly in the early phase of infection.
Despite kinetic variations, the host efficiently clears all studied SARS-CoV-2 variants post-peak viral load.
These findings contribute to understanding SARS-CoV-2 pathogenesis and inform prevention strategies.